Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) EBT (2016 - 2025)

SRx Health Solutions' EBT history spans 16 years, with the latest figure at -$16.7 million for Q2 2025.

  • For Q2 2025, EBT fell 614.69% year-over-year to -$16.7 million; the TTM value through Jun 2025 reached -$7.6 million, up 64.55%, while the annual FY2024 figure was $4.2 million, 118.41% up from the prior year.
  • EBT reached -$16.7 million in Q2 2025 per SRXH's latest filing, down from -$962000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $24.8 million in Q2 2021 to a low of -$24.4 million in Q4 2022.
  • Average EBT over 5 years is -$4.0 million, with a median of -$3.5 million recorded in 2021.
  • Peak YoY movement for EBT: soared 298.21% in 2021, then tumbled 614.69% in 2025.
  • A 5-year view of EBT shows it stood at -$5.0 million in 2021, then plummeted by 383.23% to -$24.4 million in 2022, then surged by 39.72% to -$14.7 million in 2023, then surged by 157.9% to $8.5 million in 2024, then tumbled by 296.1% to -$16.7 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's EBT are -$16.7 million (Q2 2025), -$962000.0 (Q1 2025), and $8.5 million (Q4 2024).